Performance of the carestart™ G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening
Development of reliable, easy-to-use, rapid diagnostic tests (RDTs) to detect glucose-6-phosphate dehydrogenase (G6PD) deficiency at point of care is essential to deploying primaquine therapies as part of malaria elimination strategies. We assessed a kit under research and development called CareSta...
Main Authors: | Kim, S, Nguon, C, Guillard, B, Duong, S, Chy, S, Sum, S, Nhem, S, Bouchier, C, Tichit, M, Christophel, E, Taylor, W, Baird, J, Menard, D |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2011
|
Similar Items
-
Performance of the CareStart™ G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening.
by: Kim, S, et al.
Published: (2011) -
Modelling primaquine-induced haemolysis in G6PD deficiency
by: White, N, et al.
Published: (2017) -
Modelling primaquine-induced haemolysis in G6PD deficiency
by: James Watson, et al.
Published: (2017-02-01) -
Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria
by: Taylor, WRJ, et al.
Published: (2021) -
Assessment of CareStart G6PD rapid diagnostic test and CareStart G6PD biosensor in Mauritania
by: Oum Kelthoum Mamadou Djigo, et al.
Published: (2021-08-01)